These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10329080)

  • 1. Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarction.
    Maas AC; van Domburg RT; Deckers JW; Vermeer F; Remme WJ; Kamp O; Manger Cats V; Simoons ML
    Eur Heart J; 1999 Jun; 20(11):819-26. PubMed ID: 10329080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands.
    Simoons ML; Vos J; Tijssen JG; Vermeer F; Verheugt FW; Krauss XH; Cats VM
    J Am Coll Cardiol; 1989 Dec; 14(7):1609-15. PubMed ID: 2584547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.
    Zijlstra F; de Boer MJ; Beukema WP; Liem AL; Reiffers S; Huysmans D; Hoorntje JC; Suryapranata H; Simoons ML
    Eur Heart J; 1996 Mar; 17(3):382-7. PubMed ID: 8737211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.
    Zijlstra F; Hoorntje JC; de Boer MJ; Reiffers S; Miedema K; Ottervanger JP; van 't Hof AW; Suryapranata H
    N Engl J Med; 1999 Nov; 341(19):1413-9. PubMed ID: 10547403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three life years gained after reperfusion therapy in acute myocardial infarction: 25-30 years after a randomized controlled trial.
    Domburg RT; Hendriks JM; Kamp O; Smits P; Melle Mv; Schenkeveld L; Bax JJ; Simoons ML
    Eur J Prev Cardiol; 2012 Dec; 19(6):1316-23. PubMed ID: 22013152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.
    Vermeer F; Simoons ML; de Zwaan C; van Es GA; Verheugt FW; van der Laarse A; van Hoogenhuyze DC; Azar AJ; van Dalen FJ; Lubsen J
    Br Heart J; 1988 May; 59(5):527-34. PubMed ID: 3132962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction.
    van Domburg RT; Sonnenschein K; Nieuwlaat R; Kamp O; Storm CJ; Bax JJ; Simoons ML
    J Am Coll Cardiol; 2005 Jul; 46(1):15-20. PubMed ID: 15992629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the long term effects of thrombolytic agents.
    van Domburg RT; Boersma E; Simoons ML
    Drugs; 2000 Aug; 60(2):293-305. PubMed ID: 10983734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Favorable long-term results of primary percutaneous transluminal coronary angioplasty in acute myocardial infarction compared to intravenous streptokinase treatment; a randomized study].
    Liem AL; Zijlstra F
    Ned Tijdschr Geneeskd; 1995 Dec; 139(49):2564-7. PubMed ID: 8657319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.
    Every NR; Parsons LS; Hlatky M; Martin JS; Weaver WD
    N Engl J Med; 1996 Oct; 335(17):1253-60. PubMed ID: 8857004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early infarct artery collateral flow does not improve long-term survival following thrombolytic therapy for acute myocardial infarction.
    Nicolau JC; Nogueira PR; Pinto MA; Serrano CV; Garzon SA
    Am J Cardiol; 1999 Jan; 83(1):21-6. PubMed ID: 10073779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location.
    Henriques JP; Zijlstra F; van 't Hof AW; de Boer MJ; Dambrink JH; Gosselink AT; Hoorntje JC; Ottervanger JP; Suryapranata H
    Heart; 2006 Jan; 92(1):75-9. PubMed ID: 15831596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
    Kaul P; Armstrong PW; Chang WC; Naylor CD; Granger CB; Lee KL; Peterson ED; Califf RM; Topol EJ; Mark DB
    Circulation; 2004 Sep; 110(13):1754-60. PubMed ID: 15381645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy.
    de Boer MJ; Ottervanger JP; van 't Hof AW; Hoorntje JC; Suryapranata H; Zijlstra F;
    J Am Coll Cardiol; 2002 Jun; 39(11):1723-8. PubMed ID: 12039482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy in Europe: current status.
    Vahanian A
    Eur Heart J; 1996 Sep; 17 Suppl E():21-7. PubMed ID: 11824000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. GISSI Investigators.
    Volpi A; Cavalli A; Santoro E; Tognoni G
    Circulation; 1990 Oct; 82(4):1279-88. PubMed ID: 2205418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
    Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
    J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.